Companies / ATAI Life Sciences B.V.
ATAI Life Sciences B.V.
ATAICIK 1840904
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | Apeiron Investment Group Ltd. 10% owner | Buy Open-market buy | Common Shares | $22.76M | +10.8M +36.46% | 40,555,215 | high |
| Aug 14, 2025 | Apeiron Investment Group Ltd. 10% owner | Buy Open-market buy | Common Shares | $19.00M | +8.7M +20.48% | 51,045,214 | high |
| Jun 22, 2021 | Apeiron Investment Group Ltd. 10% owner | Buy Open-market buy | Common Shares | $10.50M | +700K +3.59% | 20,185,200 | high |
| Jun 22, 2021 | Angermayer Christian Director | Buy Open-market buy | Common Shares | $10.50M | +700K +3.59% | 20,185,200 | high |
| Mar 24, 2025 | Apeiron Investment Group Ltd. 10% owner | Buy Open-market buy | Common Shares | $2.52M | +1.8M +4.44% | 42,369,415 | high |
| Mar 29, 2023 | Apeiron Investment Group Ltd. 10% owner | Buy Open-market buy | Common Shares | $1.60M | +1.2M +3.93% | 32,086,697 | high |
| Apr 20, 2022 | Apeiron Investment Group Ltd. 10% owner | Buy Open-market buy | Common Shares | $344.5K | +68K +4.58% | 1,546,223 | medium |
| Apr 21, 2022 | Apeiron Investment Group Ltd. 10% owner | Buy Open-market buy | Common Shares | $340.0K | +69K +4.44% | 1,614,911 | medium |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ATAI | common | 45822R101 |